Pharmacokinetics and metabolism of O-(chloroacetyl-carbamoyl) fumagillol (TNP-470, AGM-1470) in rhesus monkeys Erika Cretton-ScottLaurent PlacidiJean-Pierre Sommadossi ORIGINAL ARTICLE Pages: 117 - 122
Efficacy of lonidamine combined with different DNA-damaging agents in the treatment of the MX-1 tumor xenograft G. PratesiMichelandrea De CesareFranco Zunino ORIGINAL ARTICLE Pages: 123 - 128
Pharmacokinetics and toxicity of oral and intravenous lonidamine in dogs G. S. PriceRodney L. PageD. E. Thrall ORIGINAL ARTICLE Pages: 129 - 135
A convenient tubulin-based quantitative assay for paclitaxel (Taxol) derivatives more effective in inducing assembly than the parent compound Chii M. LinYuan Q. JiangE. Hamel ORIGINAL ARTICLE Pages: 136 - 140
Effect of the exposure dose of etoposide on the cell growth and cell kinetics of human ovarian cancer cells Yuji OhishiK. FujiwaraIchiro Kohno ORIGINAL ARTICLE Pages: 141 - 146
Intrasubject variation in children of ifosfamide pharmacokinetics and metabolism during repeated administration A. V. BoddyS. Murray YuleJeffrey R. Idle ORIGINAL ARTICLE Pages: 147 - 154
Biotransformation of the platinum drug JM216 following oral administration to cancer patients F. I. RaynaudP. MistryK. R. Harrap ORIGINAL ARTICLE Pages: 155 - 162
Analysis of HMG protein binding to DNA modified with the anticancer drug cisplatin Jonathan E. CryerSteven W. JohnsonP. C. Billings ORIGINAL ARTICLE Pages: 163 - 168
Comparison of several antiangiogenic regimens alone and with cytotoxic therapies in the Lewis lung carcinoma B. A. TeicherSylvia A. HoldenKrishna Menon ORIGINAL ARTICLE Pages: 169 - 177
Lack of in vivo crossresistance with gemcitabine against drug-resistant murine P388 leukemias W. R. WaudKaren S. GilbertJohn F. Worzalla ORIGINAL ARTICLE Pages: 178 - 180
Kinetic parameters for reversal of the multidrug pump as measured for drug accumulation and cell killing L.-B. LanSuhail AyeshW. D. Stein ORIGINAL ARTICLE Pages: 181 - 190
Treatment of metastatic malignant melanoma with cisplatin plus tamoxifen J. FeliuM. Gonzáles BarónONCOPAZ Cooperative Group CLINICAL TRIAL REPORT Pages: 191 - 194
5-Methyltetrahydrofolate or 5-formyltetrahydrofolic acid to modulate 5-fluorouracil’s cytotoxic activity in vivo? A phase II study in patients with advanced colon cancer C. PortaMauro MoroniGiuseppe Nastasi CLINICAL TRIAL REPORT Pages: 195 - 197
Comparison of the uptake of retinoids 13-cis-retinoic acid and Ro 13-6298 delivered to HL-60 cells by serum albumin or low-density lipoprotein R. MouawadSaïk UrienGérard Bastian SHORT COMMUNICATION Pages: 198 - 201